[Diagnosis of and therapy for eosinophilic otitis media and paranasal sinusitis--preservation therapy for eosinophilic otitis media according to the classification].
Matsubara
Atsushi
A
D000284:Administration, Oral; D018926:Anti-Allergic Agents / Q000008:administration & dosage; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives; D004359:Drug Therapy, Combination; D004802:Eosinophilia / Q000145:classification / Q000188:drug therapy*; D005938:Glucocorticoids / Q000008:administration & dosage*; D006493:Heparin / Q000008:administration & dosage; D039563:Histamine H1 Antagonists, Non-Sedating / Q000008:administration & dosage; D006801:Humans; D007267:Injections; D010033:Otitis Media / Q000145:classification / Q000188:drug therapy*; D014221:Triamcinolone / Q000008:administration & dosage
D018926:Anti-Allergic Agents; D005938:Glucocorticoids; D039563:Histamine H1 Antagonists, Non-Sedating; D014221:Triamcinolone; C028994:betamethasone sodium phosphate; D006493:Heparin; D001623:Betamethasone